Rigel Pharmaceuticals RIGL Contingent liabilities
Contingent liabilities at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's contingent liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rigel Pharmaceuticals's contingent liabilities?
- Rigel Pharmaceuticals (RIGL) reported contingent liabilities of $5M in Q1 2026.
- What does contingent liabilities mean?
- This represents the fair value of potential future payments to sellers of acquired assets or businesses, contingent upon the achievement of specific performance milestones. It reflects the financial risk associated with integration and the potential for future cash outflows based on operational success. Investors track this to understand the company's long-term obligations tied to inorganic growth strategies.